- Home
- BXC vs ZVRA Comparison
BXC vs ZVRA Comparison
Compare BXC & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BXC
- ZVRA
- Stock Information
- Founded
- BXC 2004
- ZVRA 2006
- Country
- BXC United States
- ZVRA United States
- Employees
- BXC 2000
- ZVRA N/A
- Industry
- BXC Wholesale Distributors
- ZVRA Biotechnology: Pharmaceutical Preparations
- Sector
- BXC Consumer Discretionary
- ZVRA Health Care
- Exchange
- BXC Nasdaq
- ZVRA Nasdaq
- Market Cap
- BXC 669.0M
- ZVRA 627.7M
- IPO Year
- BXC 2004
- ZVRA 2015
- Fundamental
- Price
- BXC $86.13
- ZVRA $8.95
- Analyst Decision
- BXC Strong Buy
- ZVRA Strong Buy
- Analyst Count
- BXC 3
- ZVRA 10
- Target Price
- BXC $91.00
- ZVRA $22.67
- AVG Volume (30 Days)
- BXC 100.9K
- ZVRA 1.7M
- Earning Date
- BXC 10-28-2025
- ZVRA 08-12-2025
- Dividend Yield
- BXC N/A
- ZVRA N/A
- EPS Growth
- BXC N/A
- ZVRA N/A
- EPS
- BXC 3.42
- ZVRA N/A
- Revenue
- BXC $2,947,258,000.00
- ZVRA $62,020,000.00
- Revenue This Year
- BXC $2.01
- ZVRA $329.57
- Revenue Next Year
- BXC $4.48
- ZVRA $55.29
- P/E Ratio
- BXC $25.19
- ZVRA N/A
- Revenue Growth
- BXC N/A
- ZVRA 161.81
- 52 Week Low
- BXC $63.14
- ZVRA $6.19
- 52 Week High
- BXC $134.79
- ZVRA $13.16
- Technical
- Relative Strength Index (RSI)
- BXC 63.59
- ZVRA 35.11
- Support Level
- BXC $80.67
- ZVRA $8.65
- Resistance Level
- BXC $84.68
- ZVRA $9.48
- Average True Range (ATR)
- BXC 2.89
- ZVRA 0.38
- MACD
- BXC 0.42
- ZVRA -0.03
- Stochastic Oscillator
- BXC 87.06
- ZVRA 20.27
About BXC Bluelinx Holdings Inc.
BlueLinx Holdings Inc is engaged in the wholesale distribution of residential and commercial building products. Its business products are split into two categories: Structural products include items such as lumber, plywood, oriented strand board, rebar, and remesh and Specialty products include items such as engineered wood, siding, millwork, outdoor living, specialty lumber and panels, and industrial products. The company's operations are carried out throughout the United States.
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.